Donate For Public and Patients Store Search

U088 - Hyperhidrosis: Update on Therapeutics

Monday, March 4; 4:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Identify how hyperhidrosis affects quality of life
  • Utilize new treatments for hyperhidrosis

Description

After several years of no innovation in he treatment of hyperhidrosis one new topical agent is on the market and several new treatments, topical and systemic, are in development. This session will describe he clinical trials for new agents and provide practical pearls for treatment of this disease which can ruin quality of life.

Disclosures

  • Pariser, David Michael, MD: Abbott Laboratories – I(Grants/Research Funding); Almirall – I(Grants/Research Funding); Amgen – I(Grants/Research Funding); AOBiome, LLC – I(Grants/Research Funding); Asana Biosciences, LLC – I(Grants/Research Funding); Atacama Therapeutics – C(H); Bickel Biotechnology – C(H), I(Grants/Research Funding); Biofrontera AG – C(H); BMS – Data Safety Monitoring Board(H); Celgene Corporation – C(H), I(Grants/Research Funding); Dermavant Sciences – I(Grants/Research Funding); Dermira – C(H), I(Grants/Research Funding); Eli Lilly and Company – I(Grants/Research Funding); LEO Pharma, US – C(H), I(Grants/Research Funding), I(H); Menlo Therapeutics – I(Grants/Research Funding); Merck & Co., Inc – I(Grants/Research Funding); Novartis Pharmaceuticals Corp. – C(H), I(Grants/Research Funding); Novo Nordisk A/S – I(Grants/Research Funding); Ortho Dermatologics – I(Grants/Research Funding); Pfizer Inc. – A(H), I(H); Regeneron – C(H), I(Grants/Research Funding); Sanofi – C(H); Stiefel a GSK company – I(Grants/Research Funding); TDM SurgiTech, Inc. – C(H); TheraVida – C(H); Valeant Pharmaceuticals International – C(H), I(Grants/Research Funding);
Schedule
Monday, March 4
4:30 PM
Dr. Pariser / New and emerging treatments for hyperhidrosis
Event Details
  • Date
    Monday, March 4
  • Time
    4:30 PM - 5:30 PM
  • Location
    Room 102B
  • CME Credits
    1.00
  • Type
Directors/Co-Directors
  • David Michael Pariser, MD, FAAD